RenovoRx (RNXT) director reorganizes indirect share holdings via trust

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

RenovoRx, Inc. director Una S. Ryan, through The Una S. Ryan Revocable Trust, reported several "other" transactions in RenovoRx common stock classified as restructuring events rather than open-market trades. The filing shows a total of 97,165 shares involved in these non-derivative restructurings, all held indirectly by the trust after the reported changes.

Footnotes explain that the activity reflects distributions of RenovoRx shares from Astria Fund and Golden Seeds Venture Fund GP, entities where Ryan is a non-managing member. These entries reorganize how her indirect holdings are structured, with no reported open-market buying or selling.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider RYAN UNA S

Role null

Type	Security	Shares	Price	Value
Other	Common Stock	26,838	$0.9315	$25K
Other	Common Stock	16,206	$1.6215	$26K
Other	Common Stock	47,789	$4.19	$200K
Other	Common Stock	6,332	$3.95	$25K

Holdings After Transaction: Common Stock — 80,959 shares (Indirect, The Una S. Ryan Revocable Trust)

Footnotes (1)

Reflects distribution from Astria Fund, of which the reporting person is a non-managing member. Reflects distribution from Golden Seeds Venture Fund GP, of which the reporting person is a non-managing member.

Key Figures

Restructuring shares total: 97,165 shares Transaction 1 size: 47,789 shares at $4.19 Transaction 2 size: 6,332 shares at $3.95 +5 more

8 metrics

Restructuring shares total 97,165 shares Total shares in restructuring-type transactions

Transaction 1 size 47,789 shares at $4.19 Common stock, transaction code J on 2022-03-03

Transaction 2 size 6,332 shares at $3.95 Common stock, transaction code J on 2022-03-03

Transaction 3 size 26,838 shares at $0.9315 Common stock, transaction code J on 2022-04-22

Transaction 4 size 16,206 shares at $1.6215 Common stock, transaction code J on 2022-04-22

Holdings after 2022-04-22 entry 97,165 shares Indirectly held through The Una S. Ryan Revocable Trust

Interim holdings 80,959 shares Total shares following one 2022-04-22 restructuring entry

Earlier holdings 54,121 shares Total shares following one 2022-03-03 restructuring entry

Key Terms

Other acquisition or disposition, non-derivative, indirect ownership, restructuring, +1 more

5 terms

Other acquisition or disposition financial

"transaction_code_description": "Other acquisition or disposition""

non-derivative financial

"transaction_type": "non-derivative""

indirect ownership financial

"ownership_type": "indirect""

restructuring financial

"restructuringCount": 4, "restructuringShares": 97165"

Restructuring is a deliberate rearrangement of a company’s operations, finances, or ownership—like reorganizing a cluttered house to run more efficiently—often involving cost cuts, asset sales, debt changes, or staff moves. Investors pay attention because restructuring can improve profitability and free up cash, but it can also signal distress, incur one-time costs, or dilute shareholder value; its success affects future earnings and stock performance.

Revocable Trust financial

"nature_of_ownership": "The Una S. Ryan Revocable Trust""

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/24/2026 - 05:20 PM Accepted by SEC EDGAR 06/24/2026 - 05:20 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RYAN UNA S

(Last)

(First)

(Middle)

C/O RENOVORX, INC.

2570 W EL CAMINO REAL, SUITE 640

(Street)

MOUNTAIN VIEW

CALIFORNIA

94040

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2022

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/03/2022	03/03/2022	J⁽¹⁾		47,789	A	$4.19	47,789	I	The Una S. Ryan Revocable Trust
Common Stock	03/03/2022	03/03/2022	J⁽¹⁾		6,332	A	$3.95	54,121	I	The Una S. Ryan Revocable Trust
Common Stock	04/22/2022	04/22/2022	J⁽²⁾		26,838	A	$0.9315	80,959	I	The Una S. Ryan Revocable Trust
Common Stock	04/22/2022	04/22/2022	J⁽²⁾		16,206	A	$1.6215	97,165	I	The Una S. Ryan Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects distribution from Astria Fund, of which the reporting person is a non-managing member.

2. Reflects distribution from Golden Seeds Venture Fund GP, of which the reporting person is a non-managing member.

	/s/ Una S. Ryan	06/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did RenovoRx (RNXT) report for Una S. Ryan?

RenovoRx reported that Una S. Ryan’s revocable trust recorded several “other” transactions in common stock, classified as restructuring events. These reflected distributions of shares from investment funds into the trust, changing the structure of her indirect holdings without open-market buying or selling.

How many RenovoRx (RNXT) shares were involved in Una S. Ryan’s restructuring?

The filing shows 97,165 RenovoRx common shares involved in restructuring-type transactions. These non-derivative entries reflect distributions into The Una S. Ryan Revocable Trust, consolidating her indirect ownership position rather than indicating traditional market purchases or sales of RNXT stock.

Were Una S. Ryan’s RenovoRx (RNXT) transactions open-market buys or sells?

No, the transactions are coded as “J” for other acquisition or disposition, not open-market buys or sells. They are described as distributions from Astria Fund and Golden Seeds Venture Fund GP into her revocable trust, reorganizing indirect ownership instead of trading RNXT in the market.

What is The Una S. Ryan Revocable Trust’s role in RenovoRx (RNXT) holdings?

The Una S. Ryan Revocable Trust is listed as the indirect owner of the reported RenovoRx common shares. All Form 4 entries show indirect ownership through this trust, meaning the trust, not Ryan personally, is the direct holder of the RNXT shares after the restructuring transactions.

How are Astria Fund and Golden Seeds Venture Fund GP linked to RenovoRx (RNXT) shares?

Footnotes state the transactions reflect distributions from Astria Fund and Golden Seeds Venture Fund GP, where Una S. Ryan is a non-managing member. These entities distributed RenovoRx shares to her revocable trust, driving the restructuring entries without indicating discretionary buying or selling of RNXT stock.